Advertisement
Advertisement
MDLN
M
Medline Inc. Class A common stock
42.72
USDSponsored
-0.87
-2.00%
Mar 20, 15:59 UTC -4
Closed
After-Market
42.31
-0.41
-0.96%
MDLN Earnings Reports
Positive Surprise Ratio
MDLN beat 0 of 1 last estimates.
0%
Next Report
Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/--
Implied change from Q4 25 (Revenue/ EPS)
--
/--
Implied change from Q-- -- (Revenue/ EPS)
--
/--
Medline Inc. Class A common stock earnings per share and revenue
On Feb 25, 2026, MDLN reported earnings of 0.01 USD per share (EPS) for Q4 25, missing the estimate of 0.25 USD, resulting in a -96.06% surprise. Revenue reached 7.79 billion, compared to an expected 7.70 billion, with a 1.15% difference. The market reacted with a -3.62% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Capricor Therapeutics Inc
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.55
Actual
-$0.62
Surprise
-12.56%
Kestra Medical Technologies, Ltd. Common Stock
Report Date
Mar 17, 2026 For Q3 26
Estimate
-$0.60
Actual
-$0.61
Surprise
-0.39%
Brainsway Ltd. - ADR
Report Date
Mar 11, 2026 For Q4 25
Estimate
$0.13
Actual
$0.26
Surprise
+98.02%
Sundial Growers Inc. Common Shares
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.01
Actual
$0.04
Surprise
+499.62%
High Tide Inc. Common Shares
Report Date
Mar 17, 2026 For Q1 26
Estimate
$0.00
Actual
$0.01
Surprise
+447.68%
MacroGenics, Inc.
Report Date
Mar 09, 2026 For Q4 25
Estimate
-$0.29
Actual
-$0.23
Surprise
+22.40%
Apyx Medical Corporation Common Stock
Report Date
Mar 10, 2026 For Q4 25
Estimate
-$0.05
Actual
-$0.03
Surprise
+48.63%
Exagen Inc. Common Stock
Report Date
Mar 10, 2026 For Q4 25
Estimate
-$0.19
Actual
-$0.20
Surprise
-4.22%
Biote Corp. Class A Common Stock
Report Date
Mar 11, 2026 For Q4 25
Estimate
$0.05
Actual
$0.06
Surprise
+17.65%
Nephros Inc.
Report Date
Mar 12, 2026 For Q4 25
Estimate
$0.01
Actual
$0.08
Surprise
+684.31%
FAQ
What were Medline Inc. Class A common stock's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Medline Inc. Class A common stock reported EPS of $0.01, missing estimates by -96.06%, and revenue of $7.79B, 1.15% above expectations.
How did the market react to Medline Inc. Class A common stock's Q4 2025 earnings?
The stock price moved down -3.62%, changed from $49.99 before the earnings release to $48.18 the day after.
When is Medline Inc. Class A common stock expected to report next?
The next earning report is scheduled for --.
What are the forecasts for Medline Inc. Class A common stock's next earnings report?
Based on --
analysts, Medline Inc. Class A common stock is expected to report EPS of -- and revenue of -- for Q-- --.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement